Stay updated on Efficacy of OBE2109 in Uterine Fibroids Clinical Trial
Sign up to get notified when there's something new on the Efficacy of OBE2109 in Uterine Fibroids Clinical Trial page.

Latest updates to the Efficacy of OBE2109 in Uterine Fibroids Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check19 days agoChange DetectedThe Locations section was updated to list study sites by state (Alabama, Arizona, California, etc.), and the older state-location list along with the HHS Vulnerability Disclosure entry were removed.SummaryDifference1%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed, and the revision status shows as v3.3.2. The previous wording describing PubMed publications as automatically created by ClinicalTrials.gov and tied to the NCT number has been removed.SummaryDifference0.1%

- Check55 days agoChange DetectedRemoved the banner notice about government funding impacting site updates and the NIH Clinical Center's operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check69 days agoChange DetectedCore study information remains unchanged; the screenshots show only minor UI/layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check90 days agoChange DetectedAdded a new literature citation about linzagolix (PRIMROSE 1 & 2) with details; no deletions were made.SummaryDifference1%

- Check97 days agoChange DetectedThe page now displays an updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

Stay in the know with updates to Efficacy of OBE2109 in Uterine Fibroids Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of OBE2109 in Uterine Fibroids Clinical Trial page.